A new study suggests an RNA-based therapy could help semaglutide target more fat while reducing the lean-muscle loss associated with GLP-1 weight loss.
Inc.com
This Experimental Treatment Could Make Wegovy and Ozempic Even More Effective
Shown as published in the source's RSS feed. IndiaAIFounders doesn't link out to third-party sites — this is the complete detail available from the feed itself.